Refine by
Nursing Staff Articles & Analysis
16 news found
Individual dosimetry monitoring in a hospital environment is a key component of the radiation protection system, designed to measure and control the doses of ionizing radiation received by exposed workers. This monitoring is mandatory under current regulations to limit the impact of radiation on staff health while enabling them to carry out diagnostic and treatment procedures such as X-rays and ...
As we look into the new year, the healthcare landscape in the UK is undergoing a number of changes. From digital transformation to evolving regulations, healthcare organisations across the UK are facing a number of challenges in 2024. We delve into five potential challenges confronting healthcare providers across the UK to help them prepare for the year ahead. ...
Combining capabilities to develop breakthrough technologies for transforming surgery. Hospitals and Surgery Centers face many challenges in surgery as they work to recover from COVID. Directors of Perioperative Services, Surgeons, OR Staff and OR managers are facing high levels of stress with maintaining quality patient care, increasing surgical case volume from backlogs, while at the same time ...
A Remote Clinical Lead Named “Flo” Helps Hospitals Implement Early Warning and Telehealth Tools Designed to Help Nurses Manage Patients; Delivers a Welcome Distraction While clinicians rely more than ever on technology to help provide adequate care safely, hospital quarantines have rendered it near impossible to deploy new tools at the bedside, until Flo. Flo is PeriGen’s ...
LightDeck Diagnostics, the company leveraging planar waveguide technology to deliver lab-quality diagnostics in minutes, today received a $2M contract from HJF, as funded by the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) and the Department of Defense (DoD). The funds will be used to develop a rapid, quantitative, multiplexed test for ...
Drs. Ondrej Choutka, MD, a neurosurgeon, and Lindsay Sales, MD, a radiation oncologist at Saint Alphonsus Regional Medical Center in Boise, have become the first doctors in the Pacific Northwest to utilize a new treatment for brain tumors. They implanted the FDA-cleared GammaTile therapy in a 44-year-old patient with a malignant brain tumor. The current standard of care for patients with ...
USA. Ergotrics is pleased to present the world’s first inflatable prone ventilation support to improve prone ventilation in the Intensive Care Unit (ICU). Scientific studies highlight the benefits of optimized PEEP and long recruitment for ARDS patients ventilated in alternating supine/prone position, but it is one of the most challenging and ergonomically demanding position changes for ...
UVision360, Inc., an innovative medical device company, announces today that the U.S. Food and Drug Administration (FDA) has approved the Company's expanded reprocessing procedures for use with the LUMINELLE DTx System. This expansion will allow the LUMINELLE DTx System to be more fully utilized in broader settings such as Hospital Systems and Outpatient Surgical Centers. It will also support ...
Oxford Optronix Ltd is delighted to announce that it has received a UK government grant from the National Institute of Health Research (NIHR) to help fund the development of the world’s first device for reliably detecting and reporting adult faecal incontinence. Commenting on the award, Dr Andy Obeid, CEO of Oxford Optronix said, ‘Faecal Incontinence occurs when someone is unable to ...
NEW YORK, February 18, 2021 — Woolsey Pharmaceuticals, a clinical-stage company developing treatments for neurodegenerative diseases, today announced dosing of the first patient with BRAVYL in its FOUND (Fasudil fOr Uncontrolled waNDering) study for Alzheimer’s and Vascular Dementia patients who have wandering behaviors of elopement and/or getting lost. The Company also announced the ...
Vascular access technology pioneer Velano Vascular this past week made its new streamlined remote training program widely available for hospitals around the nation. Initially developed with existing partners utilizing its PIVO™ needle-free blood draw device in the fight against COVID-19, the platform is now available for additional hospitals and systems in need of streamlined care. A ...
COVID-19 has gripped this country and put unprecedented strain on our healthcare system. We are grateful for the incredible character and commitment displayed by the doctors, nurses, and staff on the front lines of this fight. Thank you health care workers who continue to put the health of others first and serve patients during this pandemic. During this unprecedented time, we want to assure you ...
During their recent visit to Victoria BC for lab testing services, Second Heart Assist Chairman and CEO, Howard Leonhardt (HL), and VP of Engineering & Product Development, Alex Richardson (AR), spoke with ViVitro Lab and Interim General Manager, Rob Fraser (RF), about their work at Second Heart Assist, and Leonhardt Ventures. RF: You both have a long history with medical devices. Please ...
The FDA has granted its seal of approval to Sonavex to begin shipping its EchoSure system to providers across the U.S. A combination of 3D ultrasound imaging and advanced deep learning algorithms, the device automates visual and quantitative analysis to monitor and provide up-to-date information on blood flow following surgical procedures. “Doppler ultrasound is an accurate imaging ...
Hunterdon Medical Center, a 178-bed non-profit community hospital, and Christie Medical Holdings, Inc., a global leader in portable vein finders, today announced that use of the Christie VeinViewer® Vision2 is helping to improve the level of care provided to their patients. “A key goal for implementation of VeinViewer systems was to decrease the number of central lines placed in favor ...
Cytotoxic drugs (sometimes known as antineoplastics) Describe a group of medicines that contain chemicals which are toxic to cells, preventing their replication or growth, and so are primarily used to treat cancer. Once inside the body, their action is not generally tightly targeted, and they can produce side effects both to the patients and others who become exposed. What are the Risks? ...